---
figid: PMC9506150__molecules-27-05862-g002
pmcid: PMC9506150
image_filename: molecules-27-05862-g002.jpg
figure_link: /pmc/articles/PMC9506150/figure/molecules-27-05862-f002/
number: Figure 2
figure_title: ''
caption: The postulated mechanism of tocotrienol in protecting against glucocorticoid-induced
  osteoporosis. Tocotrienol can increase OPG secretion by osteoblasts and reduce RANKL
  secretion by osteoblasts, fibroblasts and immune cells, thus reducing osteoclasts
  formation. Tocotrienol may also suppress osteoclast formation directly. In addition,
  tocotrienol can reduce DKK1 and sclerostin levels; thus, the Wnt signalling pathway
  and osteogenesis are not inhibited.
article_title: 'Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis:
  A Mini Review of Potential Mechanisms.'
citation: Sophia Ogechi Ekeuku, et al. Molecules. 2022 Sep;27(18):5862.
year: '2022'

doi: 10.3390/molecules27185862
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI

keywords:
- antioxidant
- anti-inflammatory
- bone
- osteoblasts
- osteoporosis
- steroids

---
